“Early detection, especially for difficult-to-treat conditions, such as ovarian and pancreatic cancer, has the potential to save many lives. Therefore, this promising blood test could revolutionize cancer care, helping thousands more people to receive successful treatment, “said Sir Simon Stevens, executive director of NHS England, the National Health Authority, reports The Guardian.

Tests could indicate early where the cancer develops in the body.

The test will initially be used on 165,000 English people aged between 50 and 79, of whom 140,000 will be asymptomatic. If, following the study, it is found that the blood test can detect cancer early, it will become available to the public during this decade, according to the quoted source.

A study published by the Circulating Cell-free Genome Atlas consortium after examining the Galleri test, used on 6,689 participants, generated very encouraging results in over 50 different cancers at different stages of development.

The Galleri blood test, which checks for molecular changes, was developed by Grail, a California-based company that uses science and technology to find ways to identify early-stage cancer. The Guardian.